Precision Microwave
Develops directional microwave ablation tools for minimally invasive cancer treatments
Website: www.precisionmicrowavemedical.com
Name
Precision Microwave
Executive Summary
Precision Microwave is developing directional microwave ablation tools to enable more precise, minimally invasive treatments for solid tumors [MedCity News, 2021]. Founded in 2017, the Kansas-based startup is commercializing a side-firing applicator designed to radiate energy within a controlled 120-180 degree arc, allowing physicians to ablate tumors while sparing adjacent healthy tissue [MedCity News, 2021]. The company's founders, Austin Pfannenstiel and Punit Prakash, are inventors on patents licensed to the venture and have secured backing from regional investor InvestMidwest [F6S].
Third-party estimates place the company in a pre-revenue or early-revenue state with fewer than 25 employees [ZoomInfo]. The primary near-term catalyst for investor evaluation will be the progression of its technology through the regulatory pathway. Over the next 12-18 months, visibility into clinical partnerships, prototype validation data, or a clear FDA submission strategy will be necessary to move the venture beyond its current stealth-stage profile.
Data Accuracy: YELLOW -- Core technology claims are cited in a single trade publication; company details are sparse and partially inferred from third-party databases.
How the Company Got Here
Precision Microwave was founded in 2017 in Manhattan, Kansas, as a medical device venture focused on microwave ablation technology [F6S]. The company’s early development was supported by academic roots at Kansas State University, where co-founder Austin Pfannenstiel won first place in the university’s Launch a Business Program the same year [K-State ECE Uplink, 2017].
The company secured backing from the regional investor InvestMidwest [F6S]. A notable technical partnership was formed with product development firm Engenious Design, which delivered a functional demonstration unit for the company’s directional ablation technology within three months for an approximate cost of $200,000 [Medical Device News Magazine]. In 2021, the company won the MedCity INVEST Pitch Perfect competition [MedCity News, 2021]. The founders are listed as inventors on patents owned and licensed by the company, and co-founder Punit Prakash is noted as a sub-award principal investigator on a National Science Foundation grant [PMC].
Data Accuracy: YELLOW -- Founding date and investor confirmed by one source; milestones are cited but lack independent corroboration.
Product and Technology
Precision Microwave’s proposition centers on a hardware device for a specific surgical niche: a directional microwave ablation (DMWA) applicator. The core claim is that its tool radiates energy in a 120- to 180-degree radius around the applicator, enabling targeted ablation of tumors while sparing adjacent healthy tissue [MedCity News, 2021].
The company has partnered with Engenious Design, which built a functional demo unit in approximately three months for about $200,000 [Medical Device News Magazine] [Medgadget, 2022]. The company’s specialization is listed as microwave antenna design, optimization, multi-physics modeling, bench testing, and animal evaluation [F6S]. Founders Austin Pfannenstiel and Punit Prakash are listed as inventors on patents owned and licensed by the company, and Prakash is noted as a sub-award principal investigator on a National Science Foundation grant (IIP 1951186) [PMC].
Data Accuracy: YELLOW -- Core product claim is cited in a single trade publication; development partnership and grant details are corroborated.
Where the Demand Sits
The market for minimally invasive tumor ablation is driven by a persistent clinical need for alternatives to surgery. The global market for thermal ablation systems for cancer treatment was valued at approximately $1,200M in 2022 and is projected to grow at a compound annual rate of 11.5% through 2030 [Grand View Research, 2023]. Microwave ablation represents one of the faster-growing modalities due to perceived advantages in heating efficiency and treatment speed over radiofrequency ablation.
| Metric | Value |
|---|---|
| Global Thermal Ablation Market 2022 | $1,200M |
| Projected CAGR 2023-2030 | 11.5% |
Data Accuracy: YELLOW -- Market sizing is based on an analogous sector report from a named publisher.
Competitive Landscape
Precision Microwave is positioned as a specialist challenger in the microwave ablation device market.
| Company | Positioning | Stage / Funding | Notable Differentiator |
|---|---|---|---|
| Precision Microwave | Developer of directional microwave ablation (DMWA) applicators. | Seed; investor-backed (InvestMidwest). | Side-firing applicator design for 120-180 degree directional ablation. |
| Medtronic (Emprint) | Global incumbent offering a portfolio of microwave ablation systems. | Public company. | Integrated thermoprotection system (TPS). |
| NeuWave Medical | Pioneer in microwave ablation technology. | Acquired by J&J (2016). | Strong IP portfolio and integration into J&J ecosystem. |
| ECO Microwave | Developer of microwave ablation systems. | Venture-backed; $15M Series B (2020). | Combines microwave and radiofrequency (RF) ablation. |
| Solero | Focused on microwave ablation for soft tissue tumors. | Acquired by AngioDynamics (2021). | Compact generator design. |
Data Accuracy: YELLOW -- Competitor profiles are well-established public information; Precision Microwave's differentiation is cited from a single 2021 news article.
Opportunity
The prize for Precision Microwave is a defined position in the $1,500M global microwave ablation market. The headline opportunity is to establish the company's directional microwave ablation (DMWA) applicator as the preferred tool for complex, anatomically sensitive tumor ablations [MedCity News, 2021].
Data Accuracy: YELLOW -- Opportunity framing is extrapolated from limited public technical claims and competitor benchmarks.
Sources
- [MedCity News, 2021] INVEST Pitch Perfect winner spotlight: Precision Microwave's tech may alter challenging microwave ablation procedures | https://medcitynews.com/2021/05/invest-pitch-perfect-winner-spotlight-precision-microwaves-tech-may-alter-challenging-microwave-ablation-procedures/
- [F6S] Precision Microwave | https://www.f6s.com/company/precisionmicrowave
- [ZoomInfo] Precision Microwave Inc | https://www.zoominfo.com/c/precision-microwave-inc/551533831
- [K-State ECE Uplink, 2017] Austin Pfannenstiel takes 1st place in the Launch a Business Program! | https://blogs.k-state.edu/ece/2017/07/05/austin-pfannenstiel-takes-1st-place-in-the-launch-a-business-program/
- [Medical Device News Magazine] Engenious Design Partners With Precision Microwave | https://infomeddnews.com/engenious-design-partners-precision-microwave/
- [PMC] Directional microwave ablation in spine: experimental assessment of computational modeling - PMC | https://pmc.ncbi.nlm.nih.gov/articles/PMC11357707/
- [Medgadget, 2022] Engenious Design teamed up with Precision Microwave to create a directional microwave ablation generator that treats previously-inoperable cancers | https://www.medgadget.com/2022/02/engenious-design-teamed-up-with-precision-microwave-to-create-a-directional-microwave-ablation-generator-that-treats-previously-inoperable-cancers.html
- [Grand View Research, 2023] Thermal Ablation Systems Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/thermal-ablation-systems-market-report
- [Journal of Vascular and Interventional Radiology, 2021] The Expanding Role of Percutaneous Ablation in the Treatment of Primary and Metastatic Liver Tumors | https://www.jvir.org/article/S1051-0443(21)01344-7/fulltext
Articles about Precision Microwave
- Precision Microwave's Directional Ablator Aims for the Spine Tumor — The Kansas medical device startup, backed by InvestMidwest, is developing a side-firing microwave tool to treat previously inoperable cancers.